You are here:

Forthcoming Submissions:

PACE medicines

Name Manufacturer Submission Type Patient Group Submission Deadline SMC Meeting Date Advice Due
nusinersen (Spinraza) Biogen Idec Ltd Full submission 5/02/2018 Q2 2018 Q2 2018

Non-PACE medicines

Name Manufacturer Submission Type Patient Group Submission Deadline SMC Meeting Date Advice Due
sarilumab (Kevzara) Sanofi Genzyme Full submission 5/02/2018 6/03/2018 9/04/2018

Medicines with advice withheld pending product availability

Name Manufacturer Submission Type Patient Group Submission Deadline SMC Meeting Date Advice Due

Back